BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$66.61
−1.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 780.26x
- P/E 2028E
- 17.89x
- P/S forward
- 10.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.18x
- Price / sales
- 18.82x
- Price / cash flow
- -22.20x
Enterprise value
- Enterprise value
- $14.8B
- EV / sales
- 21.40x
- EV / EBITDA
- -24.56x
- EV / EBIT
- -27.24x
- Market cap
- $13.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026